Topics

Lexaria Bioscience Announces it has Received Four New Patents

08:48 EDT 15 Aug 2019 | Investing News Network

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that four of its pending patent applications, via its wholly-owned subsidiary Poviva Corp., have now been granted.

The post Lexaria Bioscience Announces it has Received Four New Patents appeared first on Investing News Network.

Original Article: Lexaria Bioscience Announces it has Received Four New Patents

NEXT ARTICLE

More From BioPortfolio on "Lexaria Bioscience Announces it has Received Four New Patents"

Quick Search

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...